324 related articles for article (PubMed ID: 31244224)
1. Nanobody-Targeted Photodynamic Therapy Selectively Kills Viral GPCR-Expressing Glioblastoma Cells.
De Groof TWM; Mashayekhi V; Fan TS; Bergkamp ND; Sastre Toraño J; van Senten JR; Heukers R; Smit MJ; Oliveira S
Mol Pharm; 2019 Jul; 16(7):3145-3156. PubMed ID: 31244224
[TBL] [Abstract][Full Text] [Related]
2. EGFR targeted nanobody-photosensitizer conjugates for photodynamic therapy in a pre-clinical model of head and neck cancer.
van Driel PBAA; Boonstra MC; Slooter MD; Heukers R; Stammes MA; Snoeks TJA; de Bruijn HS; van Diest PJ; Vahrmeijer AL; van Bergen En Henegouwen PMP; van de Velde CJH; Löwik CWGM; Robinson DJ; Oliveira S
J Control Release; 2016 May; 229():93-105. PubMed ID: 26988602
[TBL] [Abstract][Full Text] [Related]
3. Nanobody-targeted photodynamic therapy induces significant tumor regression of trastuzumab-resistant HER2-positive breast cancer, after a single treatment session.
Deken MM; Kijanka MM; Beltrán Hernández I; Slooter MD; de Bruijn HS; van Diest PJ; van Bergen En Henegouwen PMP; Lowik CWGM; Robinson DJ; Vahrmeijer AL; Oliveira S
J Control Release; 2020 Jul; 323():269-281. PubMed ID: 32330574
[TBL] [Abstract][Full Text] [Related]
4. The effect of subcellular localization on the efficiency of EGFR-targeted VHH photosensitizer conjugates.
van Lith SAM; van den Brand D; Wallbrecher R; Wübbeke L; van Duijnhoven SMJ; Mäkinen PI; Hoogstad-van Evert JS; Massuger L; Ylä-Herttuala S; Brock R; Leenders WPJ
Eur J Pharm Biopharm; 2018 Mar; 124():63-72. PubMed ID: 29274374
[TBL] [Abstract][Full Text] [Related]
5. In Vitro Assessment of Binding Affinity, Selectivity, Uptake, Intracellular Degradation, and Toxicity of Nanobody-Photosensitizer Conjugates.
Beltrán Hernández I; De Groof TWM; Heukers R; Oliveira S
Methods Mol Biol; 2022; 2451():505-520. PubMed ID: 35505028
[TBL] [Abstract][Full Text] [Related]
6. Photoimmunotheranostic agents for triple-negative breast cancer diagnosis and therapy that can be activated on demand.
Amoury M; Bauerschlag D; Zeppernick F; von Felbert V; Berges N; Di Fiore S; Mintert I; Bleilevens A; Maass N; Bräutigam K; Meinhold-Heerlein I; Stickeler E; Barth S; Fischer R; Hussain AF
Oncotarget; 2016 Aug; 7(34):54925-54936. PubMed ID: 27448975
[TBL] [Abstract][Full Text] [Related]
7. Nanobody-Targeted Photodynamic Therapy: Nanobody Production and Purification.
Mashayekhi V; Schooten E; van Bergen En Henegouwen PMP; Kijanka MM; Oliveira S
Methods Mol Biol; 2022; 2451():481-493. PubMed ID: 35505026
[TBL] [Abstract][Full Text] [Related]
8. Optimization of a nanomedicine-based silicon phthalocyanine 4 photodynamic therapy (Pc 4-PDT) strategy for targeted treatment of EGFR-overexpressing cancers.
Master AM; Livingston M; Oleinick NL; Sen Gupta A
Mol Pharm; 2012 Aug; 9(8):2331-8. PubMed ID: 22775587
[TBL] [Abstract][Full Text] [Related]
9. Investigation of the Therapeutic Potential of Nanobody-Targeted Photodynamic Therapy in an Orthotopic Head and Neck Cancer Model.
van Driel PBAA; Keereweer S; Lowik CWGM; Oliveira S
Methods Mol Biol; 2022; 2451():521-531. PubMed ID: 35505029
[TBL] [Abstract][Full Text] [Related]
10. EGFR-Targeted Nanobody Functionalized Polymeric Micelles Loaded with mTHPC for Selective Photodynamic Therapy.
Liu Y; Scrivano L; Peterson JD; Fens MHAM; Hernández IB; Mesquita B; Toraño JS; Hennink WE; van Nostrum CF; Oliveira S
Mol Pharm; 2020 Apr; 17(4):1276-1292. PubMed ID: 32142290
[No Abstract] [Full Text] [Related]
11. Targeted Photodynamic Therapy (PDT) of Lung Cancer with Biotinylated Silicon (IV) Phthalocyanine.
Dong W; Li K; Wang S; Qiu L; Liu Q; Xie M; Lin J
Curr Pharm Biotechnol; 2021; 22(3):414-422. PubMed ID: 32386488
[TBL] [Abstract][Full Text] [Related]
12. Nanobody-photosensitizer conjugates for targeted photodynamic therapy.
Heukers R; van Bergen en Henegouwen PM; Oliveira S
Nanomedicine; 2014 Oct; 10(7):1441-51. PubMed ID: 24394212
[TBL] [Abstract][Full Text] [Related]
13. Orthotopic Breast Cancer Model to Investigate the Therapeutic Efficacy of Nanobody-Targeted Photodynamic Therapy.
Deken MM; Bhairosingh SS; Vahrmeijer AL; Oliveira S
Methods Mol Biol; 2022; 2451():547-556. PubMed ID: 35505031
[TBL] [Abstract][Full Text] [Related]
14. Dual-selective photodynamic therapy with a mitochondria-targeted photosensitizer and fiber optic cannula for malignant brain tumors.
Kang JH; Ko YT
Biomater Sci; 2019 Jul; 7(7):2812-2825. PubMed ID: 31066391
[TBL] [Abstract][Full Text] [Related]
15. Photosensitizer IR700DX-6T- and IR700DX-mbc94-mediated photodynamic therapy markedly elicits anticancer immune responses during treatment of pancreatic cancer.
Zhang D; Xie Q; Liu Y; Li Z; Li H; Li S; Li Z; Cui J; Su M; Jiang X; Xue P; Bai M
Pharmacol Res; 2021 Oct; 172():105811. PubMed ID: 34390852
[TBL] [Abstract][Full Text] [Related]
16. Zn phthalocyanines loaded into liposomes: Characterization and enhanced performance of photodynamic activity on glioblastoma cells.
Miretti M; Tempesti TC; Prucca CG; Baumgartner MT
Bioorg Med Chem; 2020 Apr; 28(7):115355. PubMed ID: 32067893
[TBL] [Abstract][Full Text] [Related]
17. Dual Targeting of Endothelial and Cancer Cells Potentiates In Vitro Nanobody-Targeted Photodynamic Therapy.
Mashayekhi V; Xenaki KT; van Bergen En Henegouwen PMP; Oliveira S
Cancers (Basel); 2020 Sep; 12(10):. PubMed ID: 32977602
[TBL] [Abstract][Full Text] [Related]
18. Interstitial 5-ALA photodynamic therapy and glioblastoma: Preclinical model development and preliminary results.
Tetard MC; Vermandel M; Leroy HA; Leroux B; Maurage CA; Lejeune JP; Mordon S; Reyns N
Photodiagnosis Photodyn Ther; 2016 Mar; 13():218-224. PubMed ID: 26213327
[TBL] [Abstract][Full Text] [Related]
19. P-glycoprotein targeted and near-infrared light-guided depletion of chemoresistant tumors.
Mao C; Zhao Y; Li F; Li Z; Tian S; Debinski W; Ming X
J Control Release; 2018 Sep; 286():289-300. PubMed ID: 30081143
[TBL] [Abstract][Full Text] [Related]
20. The constitutive activity of the virally encoded chemokine receptor US28 accelerates glioblastoma growth.
Heukers R; Fan TS; de Wit RH; van Senten JR; De Groof TWM; Bebelman MP; Lagerweij T; Vieira J; de Munnik SM; Smits-de Vries L; van Offenbeek J; Rahbar A; van Hoorick D; Söderberg-Naucler C; Würdinger T; Leurs R; Siderius M; Vischer HF; Smit MJ
Oncogene; 2018 Jul; 37(30):4110-4121. PubMed ID: 29706656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
